|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM223580597 |
| 003 |
DE-627 |
| 005 |
20231224061012.0 |
| 007 |
tu |
| 008 |
231224s2012 xx ||||| 00| ||jpn c |
| 028 |
5 |
2 |
|a pubmed24n0745.xml
|
| 035 |
|
|
|a (DE-627)NLM223580597
|
| 035 |
|
|
|a (NLM)23254792
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a jpn
|
| 100 |
1 |
|
|a Nakayama, Masashi
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Side effects of sorafenib and countermeasures
|
| 264 |
|
1 |
|c 2012
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 25.06.2013
|
| 500 |
|
|
|a Date Revised 02.12.2018
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Administration of more than 400 mg/day of sorafenib for 1 month prolonged progression-free survival (PFS) in Japanese patients with advanced renal cell carcinoma (RCC). This indicated that it is very important to prevent and manage side effects of sorafenib avoiding drug withdrawal or dose reduction. I mention the side effects of sorafenib and countermeasures in this review
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Antineoplastic Agents
|2 NLM
|
| 650 |
|
7 |
|a Phenylurea Compounds
|2 NLM
|
| 650 |
|
7 |
|a Niacinamide
|2 NLM
|
| 650 |
|
7 |
|a 25X51I8RD4
|2 NLM
|
| 650 |
|
7 |
|a Sorafenib
|2 NLM
|
| 650 |
|
7 |
|a 9ZOQ3TZI87
|2 NLM
|
| 700 |
1 |
|
|a Arai, Yasuyuki
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Nishimura, Kazuo
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 58(2012), 11 vom: 28. Nov., Seite 635-7
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnns
|
| 773 |
1 |
8 |
|g volume:58
|g year:2012
|g number:11
|g day:28
|g month:11
|g pages:635-7
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 58
|j 2012
|e 11
|b 28
|c 11
|h 635-7
|